Matthew Beatty

756 total citations
27 papers, 323 citations indexed

About

Matthew Beatty is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Matthew Beatty has authored 27 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 5 papers in Surgery. Recurrent topics in Matthew Beatty's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (6 papers). Matthew Beatty is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (6 papers). Matthew Beatty collaborates with scholars based in United States, United Kingdom and Italy. Matthew Beatty's co-authors include Shari Pilon‐Thomas, Krithika N. Kodumudi, Amod A. Sarnaik, MacLean Hall, Dario Livio Longo, Robert J. Gillies, John E. Mullinax, Verónica Estrella, Dominique Abrahams and Patrick Innamarato and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew Beatty

23 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Beatty United States 9 170 161 73 50 46 27 323
Koji Nagaoka Japan 12 228 1.3× 241 1.5× 122 1.7× 40 0.8× 34 0.7× 27 385
Teppei Yamada Japan 11 164 1.0× 239 1.5× 81 1.1× 38 0.8× 25 0.5× 28 364
Simona Partlová Czechia 7 294 1.7× 302 1.9× 106 1.5× 60 1.2× 52 1.1× 12 497
Jimin Son South Korea 8 277 1.6× 209 1.3× 101 1.4× 29 0.6× 55 1.2× 14 438
Iñaki Eguren‐Santamaría Spain 7 223 1.3× 203 1.3× 83 1.1× 22 0.4× 39 0.8× 17 394
Kelli A. Connolly United States 6 312 1.8× 305 1.9× 113 1.5× 27 0.5× 52 1.1× 13 479
Dylan T. Ammons United States 6 294 1.7× 279 1.7× 131 1.8× 24 0.5× 49 1.1× 16 477
Antonin Saldmann France 6 205 1.2× 298 1.9× 92 1.3× 21 0.4× 25 0.5× 9 409
Antonina Avanzi United States 6 368 2.2× 352 2.2× 109 1.5× 45 0.9× 44 1.0× 7 591
Lillian Sun United States 7 298 1.8× 378 2.3× 120 1.6× 45 0.9× 36 0.8× 9 508

Countries citing papers authored by Matthew Beatty

Since Specialization
Citations

This map shows the geographic impact of Matthew Beatty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Beatty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Beatty more than expected).

Fields of papers citing papers by Matthew Beatty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Beatty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Beatty. The network helps show where Matthew Beatty may publish in the future.

Co-authorship network of co-authors of Matthew Beatty

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Beatty. A scholar is included among the top collaborators of Matthew Beatty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Beatty. Matthew Beatty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tordesillas, Leticia, Matthew Beatty, Dongliang Du, et al.. (2025). CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion. Journal for ImmunoTherapy of Cancer. 13(4). e011066–e011066. 4 indexed citations
2.
Chahoud, Jad, Marine Potez, Michael Carter, et al.. (2025). Optimizing clear cell renal cell carcinoma tumor-infiltrating lymphocytes under controlled hypoxic conditions.. Journal of Clinical Oncology. 43(5_suppl). 581–581.
3.
Jardim‐Perassi, Bruna V., Dominique Abrahams, Verónica Estrella, et al.. (2024). L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy. Biomedicines. 12(2). 461–461. 6 indexed citations
4.
Im, Hyoung‐June, et al.. (2024). Imbalance and ICA Monitoring for Multiple Battery-Electrolyser Cells in Series. 420–425. 1 indexed citations
5.
Anderson, K., Wenpeng Cao, Hui Sun Lee, et al.. (2024). A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors. Frontiers in Behavioral Neuroscience. 18. 1347543–1347543. 1 indexed citations
6.
Hall, MacLean, et al.. (2024). 887 The chromosome 19 microRNA cluster facilitates TIL-based immune evasion in human melanoma. Regular and Young Investigator Award Abstracts. A1001–A1001. 1 indexed citations
7.
Beatty, Matthew, MacLean Hall, Larissa A. Pikor, et al.. (2023). 346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers. SHILAP Revista de lepidopterología. A395–A395.
8.
Tew, Garry A., J. W. Durrand, Alexander Nesbitt, et al.. (2023). Digital health coaching to improve patient preparedness for elective lower limb arthroplasty: a quality improvement project. BMJ Open Quality. 12(4). e002244–e002244. 2 indexed citations
9.
Potez, Marine, et al.. (2023). Abstract B023: Using hypoxia to improve tumor infiltrating lymphocytes therapy in different subtypes of renal cell carcinoma. Cancer Research. 83(16_Supplement). B023–B023. 1 indexed citations
10.
Hensel, Jonathan A., Christopher Cubitt, Michael J. Schell, et al.. (2023). SARS-CoV-2 antibody response duration and neutralization following natural infection. SHILAP Revista de lepidopterología. 3(3). 100158–100158.
11.
Abrahams, Dominique, Cheryl A. Cox, Matthew Beatty, et al.. (2023). Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer. Frontiers in Immunology. 14. 1275375–1275375. 10 indexed citations
12.
Innamarato, Patrick, et al.. (2021). Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors. BMC Cancer. 21(1). 756–756. 3 indexed citations
13.
Aydın, Ahmet Murat, Matthew Beatty, Ali Hajiran, et al.. (2021). The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications. Frontiers in Immunology. 12. 628063–628063. 8 indexed citations
14.
Aydın, Ahmet Murat, Patrick Innamarato, Ali Hajiran, et al.. (2020). Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo. Journal for ImmunoTherapy of Cancer. 8(2). e001673–e001673. 7 indexed citations
15.
Zager, Jonathan S., Amod Sarnaik, Shari Pilon‐Thomas, et al.. (2020). 1123P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade. Annals of Oncology. 31. S755–S756. 4 indexed citations
16.
Innamarato, Patrick, Krithika N. Kodumudi, MacLean Hall, et al.. (2020). Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy. Molecular Therapy. 28(10). 2252–2270. 30 indexed citations
17.
Wu, Hao, Verónica Estrella, Matthew Beatty, et al.. (2020). T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nature Communications. 11(1). 4113–4113. 119 indexed citations
18.
Liang, Chia-Pin, Jing Dong, Tim N. Ford, et al.. (2019). Optical coherence tomography-guided laser marking with tethered capsule endomicroscopy in unsedated patients. Biomedical Optics Express. 10(3). 1207–1207. 14 indexed citations
19.
Piao, Zhonglie, Kanwarpal Singh, Mohammed Mehadi Hassan Chowdhury, et al.. (2018). TCT-56 High-resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury. Journal of the American College of Cardiology. 72(13). B25–B25. 1 indexed citations
20.
Beatty, Matthew, et al.. (1996). Immunology and inflammation. Gut. 38(Suppl 1). A29–A31. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Nagaoka Breakdown of academic impact, for papers by Teppei Yamada Breakdown of academic impact, for papers by Simona Partlová Breakdown of academic impact, for papers by Jimin Son Breakdown of academic impact, for papers by Iñaki Eguren‐Santamaría Breakdown of academic impact, for papers by Kelli A. Connolly Breakdown of academic impact, for papers by Dylan T. Ammons Breakdown of academic impact, for papers by Antonin Saldmann Breakdown of academic impact, for papers by Antonina Avanzi Breakdown of academic impact, for papers by Lillian Sun
Rankless by CCL
2026